Open Orphan announce Poolbeg Pharma to seek admission to AIM London Stock Exchange
Open Orphan and Poolbeg Pharma have announced they will seek admission of their shares to trading on the London Stock Exchange in a bid to raise money for clinical trial costs associated with the development of new vaccines against severe influenza.
Source: directorstalkinterviews.comPublished on 2021-06-17
Related news
- NSF Awards Georgetown University $12 . 5M to Establish Institute for Emerging Virus Research | Georgetown University Medical Center
- Clare ONeil raises concerns about Medicare numbers stolen in Optus hack
- PHOTOS : See Highland beauty spot as never before as it gets the Minecraft treatment
- Auditor Candidate Dempsey : I Will Audit and Ride the MBTA
- NASA , ESA Finalize Agreements on Climate , Artemis Cooperation
- South Africa : Minister Stella Ndabeni - Abrahams - Data and Cloud Policy Virtual Colloquim
- What should scientific temper mean in our times in India
- Dental Industry Heavyweights Join tab32 Advisory Board
- Adegbiji : Data Centre Investment Will Grow Nigeria Economy
- North Dakota Department of Public Instruction Announces State - Wide Partnership With ClassLink
- New normal needs resetting of mind
- Poolbeg Pharma IPO and funds raised provide strong platform to begin rapid growth plan
- An app carrying blood type data should be launched to protect life
- RMS Builds on Its Risk Modeler Cloud - Based Application
- Cairngorms National Park gets the Minecraft treatment